Open an account

Vicarious Surgical

RBOT · OTC

$0.0004−$0.0196 (−98.00%)TodayMarket closed ·
Prev close $0.02

About RBOT

Vicarious Surgical, Inc. a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in Waltham, Massachusetts and currently employs 26 full-time employees. The company went IPO on 2020-09-04. The firm is combining advanced miniaturized robotics, computer science, sensing and three-dimensional (3D) visualization to build a single-port surgical robot, called the Vicarious Surgical System, that helps surgeons to perform minimally invasive surgery. The Vicarious Surgical System is capable of incision sizes of approximately 1.8 centimeters. The Vicarious Surgical System consists of a camera and instrument arms, a surgeon's console and a patient cart. The Vicarious Surgical System has a high-performance stereoscopic camera that, when combined with robotic motion, provides a range of viewing capabilities and is being developed to continuously map the depth of the abdominal cavity. The Vicarious Surgical System surgeon console is designed to provide all the systems necessary for the surgeon in visualizing the surgical field and controlling all the motions of the robot.

Employees
26
Headquarters
Waltham, Massachusetts
Listed
Sep 4, 2020
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
vicarioussurgical.com

RBOT key statistics

Market cap
142.63K
Price-earnings ratio
0.00
Dividend yield
—
Average volume
42.53K
Volume
39.67K
Open price
$0.0004
High today
$0.26
Low today
$0.0004
52 Week high
$6.28
52 Week low
$0.0002

Vicarious Surgical (RBOT) at a glance

Vicarious Surgical (RBOT) last traded at $0.0004, with a market cap of 142.63K and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.0004 and $0.26. The current price is 0.0% above the day's low and 99.8% below its high.

Volume so far is 39.67K shares, in line with the average of 42.53K shares a day.

Over the past year Vicarious Surgical has ranged from $0.0002 to $6.28, and now sits 0% of the way up that range.

Vicarious Surgical met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q4 FY25 it reported -$1.57 per share against an estimate of -$1.40.

The average analyst price target is $5.10, 1274900.0% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

0%of 1 analyst rating say Buy
  • Buy0.0%
  • Hold100.0%
  • Sell0.0%
Price target · 3 analystsAvg $5.10
Low
$5.05
Now
$0.0004
High
$5.25

RBOT earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 14.1% on average.

  1. Q1 FY24: reported -$3.00 per share against an estimate of -$2.91
  2. Q2 FY24: reported -$2.59 per share against an estimate of -$2.83
  3. Q3 FY24: reported -$2.90 per share against an estimate of -$2.61
  4. Q4 FY24: reported -$2.36 per share against an estimate of -$2.74
  5. Q1 FY25: reported -$2.60 per share against an estimate of -$2.53
  6. Q2 FY25: reported -$2.23 per share against an estimate of -$2.55
  7. Q3 FY25: reported -$1.86 per share against an estimate of -$2.37
  8. Q4 FY25: reported -$1.57 per share against an estimate of -$1.40

RBOT news

  • Press releaseBusiness Wire

    Vicarious Surgical Receives Delisting Notice From NYSE

  • Press releaseBusiness Wire

    Vicarious Surgical Advances Toward Design Freeze with Successful In-Vivo Porcine Lab

  • Press releaseBusiness Wire

    Vicarious Surgical Announces Strategic Software Execution Partnership to Streamline Operations

  • Press releaseBusiness Wire

    Vicarious Surgical Announces Full Year 2026 Cash Burn Guidance

  • Press releaseBusiness Wire

    Vicarious Surgical Announces Reduction in 2025 Cash Burn Outlook

  • Press releaseBusiness Wire

    Vicarious Surgical to Participate in the Piper Sandler 37th Annual Healthcare Conference

  • Press releaseBusiness Wire

    Vicarious Surgical Reports Third Quarter 2025 Financial Results

  • Press releaseBusiness Wire

    Vicarious Surgical to Report Third Quarter 2025 Financial Results on November 12, 2025

Similar companies

Companies in the same industry as Vicarious Surgical

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.